Edmund Wilkes
Overview
Explore the profile of Edmund Wilkes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang K, Reebye V, Czysz K, Ciriello S, Dorman S, Reccia I, et al.
Mol Ther Nucleic Acids
. 2019 Dec;
19:361-370.
PMID: 31877412
Non-alcoholic fatty liver disease (NAFLD) culminates in insulin resistance and metabolic syndrome. Because there are no approved pharmacological treatment agents for non-alcoholic steatohepatitis (NASH) and NAFLD, different signaling pathways are...
2.
Wilkes E, Cutillas P
Methods Mol Biol
. 2017 Jul;
1636:199-217.
PMID: 28730481
Phosphoproteomics is a powerful platform for the unbiased profiling of kinase-driven signaling pathways. Quantitation of phosphorylation can be performed by means of either labeling or label-free mass spectrometry (MS) methods....
3.
Afzal T, Luong L, Chen D, Zhang C, Yang F, Chen Q, et al.
J Am Heart Assoc
. 2016 Dec;
5(12).
PMID: 27927633
Background: MicroRNA miR-214 has been implicated in many biological cellular functions, but the impact of miR-214 and its target genes on vascular smooth muscle cell (VSMC) proliferation, migration, and neointima...
4.
Rajeeve V, Vendrell I, Wilkes E, Torbett N, Cutillas P
Mol Cell Proteomics
. 2014 Mar;
13(6):1457-70.
PMID: 24648465
The tumor microenvironment plays key roles in cancer biology, but its impact on the regulation of signaling pathway activity in cancer cells has not been systemically investigated. We designed an...